Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Adaptation of Bordetella pertussis to the Respiratory Tract.

van Beek LF, de Gouw D, Eleveld MJ, Bootsma HJ, de Jonge MI, Mooi FR, Zomer A, Diavatopoulos DA.

J Infect Dis. 2018 May 25;217(12):1987-1996. doi: 10.1093/infdis/jiy125.

PMID:
29528444
2.

Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells.

Hovingh ES, van Gent M, Hamstra HJ, Demkes M, Mooi FR, Pinelli E.

PLoS One. 2017 Jan 11;12(1):e0170027. doi: 10.1371/journal.pone.0170027. eCollection 2017.

3.

Bordetella pertussis Isolates from Argentinean Whooping Cough Patients Display Enhanced Biofilm Formation Capacity Compared to Tohama I Reference Strain.

Arnal L, Grunert T, Cattelan N, de Gouw D, Villalba MI, Serra DO, Mooi FR, Ehling-Schulz M, Yantorno OM.

Front Microbiol. 2015 Dec 8;6:1352. doi: 10.3389/fmicb.2015.01352. eCollection 2015.

4.

Complete Genome Sequences of 11 Bordetella pertussis Strains Representing the Pandemic ptxP3 Lineage.

Bart MJ, van der Heide HG, Zeddeman A, Heuvelman K, van Gent M, Mooi FR.

Genome Announc. 2015 Nov 25;3(6). pii: e01394-15. doi: 10.1128/genomeA.01394-15.

5.

Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis.

Guevara C, Zhang C, Gaddy JA, Iqbal J, Guerra J, Greenberg DP, Decker MD, Carbonetti N, Starner TD, McCray PB Jr, Mooi FR, Gómez-Duarte OG.

Infect Dis (Lond). 2016;48(3):177-88. doi: 10.3109/23744235.2015.1100323. Epub 2015 Oct 22.

6.

Laboratory Diagnosis of Pertussis.

van der Zee A, Schellekens JF, Mooi FR.

Clin Microbiol Rev. 2015 Oct;28(4):1005-26. doi: 10.1128/CMR.00031-15. Review.

7.

Genetic Variation of Bordetella pertussis in Austria.

Wagner B, Melzer H, Freymüller G, Stumvoll S, Rendi-Wagner P, Paulke-Korinek M, Repa A, Mooi FR, Kollaritsch H, Mittermayer H, Kessler HH, Stanek G, Steinborn R, Duchêne M, Wiedermann U.

PLoS One. 2015 Jul 16;10(7):e0132623. doi: 10.1371/journal.pone.0132623. eCollection 2015.

8.

The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins.

de Gouw D, Serra DO, de Jonge MI, Hermans PW, Wessels HJ, Zomer A, Yantorno OM, Diavatopoulos DA, Mooi FR.

Emerg Microbes Infect. 2014 Aug;3(8):e58. doi: 10.1038/emi.2014.58. Epub 2014 Aug 20.

9.

The pertussis problem: classical epidemiology and strain characterization should go hand in hand.

Mooi FR, Zeddeman A, van Gent M.

J Pediatr (Rio J). 2015 Jul-Aug;91(4):315-7. doi: 10.1016/j.jped.2015.02.001. Epub 2015 Feb 20. No abstract available.

10.

Complement evasion by Bordetella pertussis: implications for improving current vaccines.

Jongerius I, Schuijt TJ, Mooi FR, Pinelli E.

J Mol Med (Berl). 2015 Apr;93(4):395-402. doi: 10.1007/s00109-015-1259-1. Epub 2015 Feb 18. Review.

11.

Studying Bordetella pertussis populations by use of SNPeX, a simple high-throughput single nucleotide polymorphism typing method.

Zeddeman A, Witteveen S, Bart MJ, van Gent M, van der Heide HG, Heuvelman KJ, Schouls LM, Mooi FR.

J Clin Microbiol. 2015 Mar;53(3):838-46. doi: 10.1128/JCM.02995-14. Epub 2015 Jan 7.

12.

Complete Genome Sequences of Bordetella pertussis Isolates B1917 and B1920, Representing Two Predominant Global Lineages.

Bart MJ, Zeddeman A, van der Heide HG, Heuvelman K, van Gent M, Mooi FR.

Genome Announc. 2014 Dec 24;2(6). pii: e01301-14. doi: 10.1128/genomeA.01301-14.

13.

Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.

van Gent M, Heuvelman CJ, van der Heide HG, Hallander HO, Advani A, Guiso N, Wirsing von Kőnig CH, Vestrheim DF, Dalby T, Fry NK, Pierard D, Detemmerman L, Zavadilova J, Fabianova K, Logan C, Habington A, Byrne M, Lutyńska A, Mosiej E, Pelaz C, Gröndahl-Yli-Hannuksela K, Barkoff AM, Mertsola J, Economopoulou A, He Q, Mooi FR.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):821-30. doi: 10.1007/s10096-014-2297-2. Epub 2014 Dec 20.

14.

Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells.

Brummelman J, Veerman RE, Hamstra HJ, Deuss AJ, Schuijt TJ, Sloots A, Kuipers B, van Els CA, van der Ley P, Mooi FR, Han WG, Pinelli E.

Infect Immun. 2015 Jan;83(1):227-38. doi: 10.1128/IAI.02197-14. Epub 2014 Oct 27.

15.

Proteomics-identified Bvg-activated autotransporters protect against bordetella pertussis in a mouse model.

de Gouw D, de Jonge MI, Hermans PW, Wessels HJ, Zomer A, Berends A, Pratt C, Berbers GA, Mooi FR, Diavatopoulos DA.

PLoS One. 2014 Aug 18;9(8):e105011. doi: 10.1371/journal.pone.0105011. eCollection 2014. Erratum in: PLoS One. 2014 Nov;9(11):e113322. Gouw, Daan de [corrected to de Gouw, Daan; Jonge, Marien I de [corrected to de Jonge, Marien I].

16.

Estimation of the serial interval of pertussis in Dutch households.

Te Beest DE, Henderson D, van der Maas NA, de Greeff SC, Wallinga J, Mooi FR, van Boven M.

Epidemics. 2014 Jun;7:1-6. doi: 10.1016/j.epidem.2014.02.001. Epub 2014 Feb 18.

17.

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyńska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR.

MBio. 2014 Apr 22;5(2):e01074. doi: 10.1128/mBio.01074-14.

18.

Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally.

de Gouw D, Hermans PW, Bootsma HJ, Zomer A, Heuvelman K, Diavatopoulos DA, Mooi FR.

PLoS One. 2014 Jan 8;9(1):e84523. doi: 10.1371/journal.pone.0084523. eCollection 2014. Erratum in: PLoS One. 2014;9(1). doi: 10.1371/annotation/1b2cfe52-aaea-4148-aa72-a74c78550192.

19.

Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies.

Lugnér AK, van der Maas N, van Boven M, Mooi FR, de Melker HE.

Vaccine. 2013 Nov 4;31(46):5392-7. doi: 10.1016/j.vaccine.2013.09.028. Epub 2013 Sep 27.

PMID:
24075918
20.

Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?

van der Maas NA, Mooi FR, de Greeff SC, Berbers GA, Spaendonck MA, de Melker HE.

Vaccine. 2013 Sep 23;31(41):4541-7. doi: 10.1016/j.vaccine.2013.07.060. Epub 2013 Aug 6.

PMID:
23933365
21.

Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.

Mooi FR, Van Der Maas NA, De Melker HE.

Epidemiol Infect. 2014 Apr;142(4):685-94. doi: 10.1017/S0950268813000071. Epub 2013 Feb 13. Review.

PMID:
23406868
22.

Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Advani A, Hallander HO, Dalby T, Krogfelt KA, Guiso N, Njamkepo E, von Könnig CH, Riffelmann M, Mooi FR, Sandven P, Lutynska A, Fry NK, Mertsola J, He Q.

J Clin Microbiol. 2013 Feb;51(2):422-8. doi: 10.1128/JCM.02036-12. Epub 2012 Nov 21.

23.

Small mutations in Bordetella pertussis are associated with selective sweeps.

van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Mooi FR.

PLoS One. 2012;7(9):e46407. doi: 10.1371/journal.pone.0046407. Epub 2012 Sep 28.

24.

Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.

de Greeff SC, de Melker HE, Westerhof A, Schellekens JF, Mooi FR, van Boven M.

Epidemiology. 2012 Nov;23(6):852-60. doi: 10.1097/EDE.0b013e31826c2b9e.

PMID:
23018969
25.

Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR.

Kallonen T, Mertsola J, Mooi FR, He Q.

Clin Microbiol Infect. 2012 Oct;18(10):E377-9. doi: 10.1111/j.1469-0691.2012.04000.x. Epub 2012 Aug 22.

26.

Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples.

de Greeff SC, Teunis P, de Melker HE, Mooi FR, Notermans DW, Elvers B, Schellekens JF.

Clin Vaccine Immunol. 2012 Sep;19(9):1452-6. doi: 10.1128/CVI.00229-12. Epub 2012 Jul 11.

27.

Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in The Netherlands.

Mooi FR, Bruisten S, Linde I, Reubsaet F, Heuvelman K, van der Lee S, King AJ.

FEMS Immunol Med Microbiol. 2012 Mar;64(2):289-91. doi: 10.1111/j.1574-695X.2011.00911.x. Epub 2011 Dec 14.

28.

Molecular typing of Bordetella parapertussis isolates circulating in Pakistan.

Bokhari H, Said F, Syed MA, Mughal A, Kazi YF, Kallonen T, He Q, King AJ, Heuvelman K, Mooi FR.

FEMS Immunol Med Microbiol. 2011 Dec;63(3):373-80. doi: 10.1111/j.1574-695X.2011.00861.x. Epub 2011 Oct 3.

29.

Pertussis in infancy and the association with respiratory and cognitive disorders at toddler age.

de Greeff SC, van Buul LW, Westerhof A, Wijga AH, van de Kassteele J, Oostvogels B, van der Maas NA, Mooi FR, de Melker HE.

Vaccine. 2011 Oct 26;29(46):8275-8. doi: 10.1016/j.vaccine.2011.08.112. Epub 2011 Sep 9.

PMID:
21907748
30.

SNP-based typing: a useful tool to study Bordetella pertussis populations.

van Gent M, Bart MJ, van der Heide HG, Heuvelman KJ, Kallonen T, He Q, Mertsola J, Advani A, Hallander HO, Janssens K, Hermans PW, Mooi FR.

PLoS One. 2011;6(5):e20340. doi: 10.1371/journal.pone.0020340. Epub 2011 May 27.

31.

Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009.

Bokhari H, Said F, Syed MA, Mughal A, Kazi YF, Heuvelman K, Mooi FR.

Scand J Infect Dis. 2011 Oct;43(10):818-20. doi: 10.3109/00365548.2011.577804. Epub 2011 May 12.

PMID:
21563881
32.

Studies on Prn variation in the mouse model and comparison with epidemiological data.

van Gent M, van Loo IH, Heuvelman KJ, de Neeling AJ, Teunis P, Mooi FR.

PLoS One. 2011 Mar 25;6(3):e18014. doi: 10.1371/journal.pone.0018014.

33.

Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs.

Advani A, Gustafsson L, Ahrén C, Mooi FR, Hallander HO.

Vaccine. 2011 Apr 18;29(18):3438-42. doi: 10.1016/j.vaccine.2011.02.070. Epub 2011 Mar 9.

PMID:
21396900
34.

Pertussis: a matter of immune modulation.

de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR.

FEMS Microbiol Rev. 2011 May;35(3):441-74. doi: 10.1111/j.1574-6976.2010.00257.x. Epub 2011 Jan 5. Review.

35.

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.

de Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, Mollema L, Mooi FR, Berbers GA.

PLoS One. 2010 Dec 1;5(12):e14183. doi: 10.1371/journal.pone.0014183.

36.

Comparative genomics of prevaccination and modern Bordetella pertussis strains.

Bart MJ, van Gent M, van der Heide HG, Boekhorst J, Hermans P, Parkhill J, Mooi FR.

BMC Genomics. 2010 Nov 11;11:627. doi: 10.1186/1471-2164-11-627.

37.

Pertussis disease burden in the household: how to protect young infants.

de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE.

Clin Infect Dis. 2010 May 15;50(10):1339-45. doi: 10.1086/652281.

PMID:
20370464
38.

[Pertussis in the Netherlands].

de Greeff SC, de Melker HE, Mooi FR.

Ned Tijdschr Geneeskd. 2010;154:A1383. Review. Dutch.

PMID:
20170575
39.

Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis.

Kurniawan J, Maharjan RP, Chan WF, Reeves PR, Sintchenko V, Gilbert GL, Mooi FR, Lan R.

Emerg Infect Dis. 2010 Feb;16(2):297-300. doi: 10.3201/eid1602.081707.

40.

Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.

Mooi FR.

Infect Genet Evol. 2010 Jan;10(1):36-49. doi: 10.1016/j.meegid.2009.10.007. Epub 2009 Oct 30. Review.

PMID:
19879977
41.

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, Diavatopoulos D, Teunis P, Nagelkerke N, Mertsola J.

Emerg Infect Dis. 2009 Aug;15(8):1206-13. doi: 10.3201/eid1508.081511.

42.

Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage.

Advani A, Van der Heide HG, Hallander HO, Mooi FR.

J Microbiol Methods. 2009 Sep;78(3):297-301. doi: 10.1016/j.mimet.2009.06.019. Epub 2009 Jul 3.

PMID:
19577594
43.

Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.

de Greeff SC, Lugnér AK, van den Heuvel DM, Mooi FR, de Melker HE.

Vaccine. 2009 Mar 18;27(13):1932-7. doi: 10.1016/j.vaccine.2009.01.106. Epub 2009 Jan 31.

PMID:
19368774
44.

An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.

van Gent M, de Greeff SC, van der Heide HG, Mooi FR.

Vaccine. 2009 Mar 18;27(13):1898-903. doi: 10.1016/j.vaccine.2009.01.111. Epub 2009 Jan 31.

PMID:
19368769
45.

Seasonal patterns in time series of pertussis.

De Greeff SC, Dekkers AL, Teunis P, Rahamat-Langendoen JC, Mooi FR, De Melker HE.

Epidemiol Infect. 2009 Oct;137(10):1388-95. doi: 10.1017/S0950268809002489. Epub 2009 Mar 30.

PMID:
19327200
46.

Improving pertussis vaccination.

Berbers GA, de Greeff SC, Mooi FR.

Hum Vaccin. 2009 Jul;5(7):497-503. Epub 2009 Jul 8. Review. No abstract available.

PMID:
19242096
47.

Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.

Stenger RM, Poelen MC, Moret EE, Kuipers B, Bruijns SC, Hoogerhout P, Hijnen M, King AJ, Mooi FR, Boog CJ, van Els CA.

Infect Immun. 2009 Feb;77(2):896-903. doi: 10.1128/IAI.00769-08. Epub 2008 Nov 17.

48.

Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains.

King AJ, van Gorkom T, Pennings JL, van der Heide HG, He Q, Diavatopoulos D, Heuvelman K, van Gent M, van Leeuwen K, Mooi FR.

BMC Genomics. 2008 Jun 30;9:311. doi: 10.1186/1471-2164-9-311. Erratum in: BMC Genomics. 2010;11:196.

49.

The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.

Banus S, Stenger RM, Gremmer ER, Dormans JA, Mooi FR, Kimman TG, Vandebriel RJ.

BMC Immunol. 2008 May 22;9:21. doi: 10.1186/1471-2172-9-21.

50.

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.

de Greeff SC, Mooi FR, Schellekens JF, de Melker HE.

Pediatr Infect Dis J. 2008 Mar;27(3):218-23. doi: 10.1097/INF.0b013e318161a2b9.

PMID:
18277916

Supplemental Content

Support Center